PHARMA
Sirona Biochem Signs LOI With Wanbang Pharma
Sirona Biochem has signed a LOI with Wanbang Pharma to develop and commercialize its SGLT2 inhibitor in China.
MicuRx Raises US$25m For US-China Antibiotic Clinical Trial
MicuRx Pharma has raised US$25 million in Series B financing to carry out clinical trials on its MRX-I antibiotic candidate.
Zoetis China JV Receives Approval For Swine Vaccine
Animal health company Zoetis has received regulatory approval by the Chinese Ministry of Agriculture for its swine vaccine, Rui Lan An.
Takeda Receives Marketing Authorization For NESINA In China
The China Food and Drug Administration has issued an Import Drug License for Takeda's type 2 diabetes drug.
Oral Rheumatoid Arthritis Treatment XELJANZ® Launched In Japan
Pfizer and Takeda Pharmaceutical have launched their rheumatoid arthritis drug XELJANZ® (tofacitinib citrate) in Japan.
Samsung BioLogics To Manufacture Antibody Drug For Bristol-Myers Squibb
Samsung BioLogics will manufacture a commercial antibody cancer drug for Bristol-Myers Squibb at its Songdo Incheon plant in South Korea.
Celsion And Zhejiang Hisun Sign MOU To Continue ThermoDox® Collaboration
Celsion and Zhejiang Hisun will continue clinical development of ThermoDox®, a heat-activated liposomal encapsulation of doxorubicin.
Lumenis To Partner Visionex In China
Lumenis Ltd. will distribute the Visionix ophthalmic and optometric diagnostics product line in China.
Serum Institute of India Acquires Rights To German TB Vaccine
The Serum Institute of India has announced plans to take a promising new tuberculosis vaccine, developed in Germany, into the clinic.
